课题基金 / 基金详情

Role of Integrins in Cardiac Myocyte Function

Role of Integrins in Cardiac Myocyte Function
整合素在心肌细胞功能中的作用
批准号:
6780378
负责人:
JOSEPH C LOFTUS
金额:
$26.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2006-07-31

项目摘要

项目成果

JOSEPH C LOFTUS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):细胞外基质(ECM)是一种 心脏力学的重要决定因素。它发挥着结构性作用, 维持肌细胞和血管的排列,防止肌细胞 收缩时的滑动。企业内容管理还发挥积极的职能作用, 力传感器整合素是ECM的主要受体, 细胞外基质与细胞内的细胞骨架和激活信号 细胞外基质粘附的信号转导途径。它们对于以下方面至关重要: 正常心脏发育、心肌细胞分化和肌节 组装件.整合素不仅介导细胞粘附,而且还作为细胞粘附分子, 生长因子刺激途径的共受体和作为机械转换器。 我们假设整合素在细胞内起着重要的信号调节剂的作用, 心脏感知和响应机械和内分泌刺激,以维持 心脏止血特别假设整合素信号传导 与G蛋白偶联受体的信号通路整合 (GPCR)来协调调节心肌细胞的肥大反应。 该提案的目的是定义整合素介导的 粘附和信号在形态和转录的变化, 定义心肌细胞的肥大反应途径。拟议 研究将利用新生大鼠的良好表征的细胞培养模型, 心室肌细胞和腺病毒基因递送。首先,我们将确定 功能获得或丧失整合素变体的表达对 肌细胞组织和肥大标志物基因表达。第二、 我们将确定FAK在整合素介导的细胞变化中的作用, 与心肌细胞肥大有关。第三,我们将确定 将整合素信号传导偶联到 GPCR激动剂诱导的心肌细胞肥大反应。研究将寻求 为了确定GPCR介导的信号传导和 整合素信号通路和整合素的关键效应分子 协同调节肾上腺素能信号通路的信号传导 肌细胞总的来说,这些研究将提供对分子生物学的见解。 作为补偿性肥大生长反应的基础的途径以及 向心力衰竭的转变对心肌细胞的进一步了解 信号通路可能导致新的治疗方法适用于 在人类心肌中发现的病理改变。
英文摘要
DESCRIPTION (provided by applicant): The extracellular matrix (ECM) is an important determinant of cardiac mechanics. It plays a structural role by maintaining the alignment of myocytes and vessels and preventing myocyte slippage during contraction. ECM also plays an active functional role as a force transducer. Integrins, the predominant receptors for the ECM, link the extracellular matrix with the intracellular cytoskeleton and activate signal transduction pathways in response to ECM adhesion. They are essential for normal cardiac development, cardiomyocyte differentiation, and sarcomere assembly. Integrins not only mediate cell adhesion, but also serve as co-receptors for growth factor stimulated pathways and as mechanotransducers. We hypothesize that integrins function as important signaling modulators in the heart sensing and responding to mechanical and endocrine stimuli to maintain cardiac hemostasis. It is specifically hypothesized that integrin signaling pathways integrate with signaling pathways from G-protein coupled receptors (GPCR) to coordinately regulate the hypertrophic response of cardiac myocytes. The objective of this proposal is to define the role of integrin mediated adhesion and signaling in the morphological and transcriptional changes that define the hypertrophic response pathway of cardiac myocytes. The proposed studies will utilize a well characterized cell culture model of neonatal rat ventricular myocytes and adenoviral gene delivery. First, we will determine the effect of the expression of gain or loss of function integrin variants on myocyte cellular organization and hypertrophic marker gene expression. Second, we will determine the role of FAK in the integrin mediated cellular changes associated with cardiac myocyte hypertrophy. Third, we will determine the mechanistic basis of the relationship that couples integrin signaling to hypertrophic response in myocytes induced by GPCR agonists. Studies will seek to identify the point of convergence between GPCR mediated signaling and integrin signaling pathways and the critical effector molecules of integrin signaling that cooperatively regulate adrenergic signaling pathways in cardiac myocytes. Overall, these studies will provide insights into the molecular pathways that underlie the compensatory hypertrophic growth response as well as the transition to cardiac failure. A greater understanding of cardiac myocyte signaling pathways may lead to new therapeutic approaches applicable to pathologic alterations found in the human myocardium.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Differential effects of Pyk2 and FAK on the hypertrophic response of cardiac myocytes.
Pyk2 和 FAK 对心肌细胞肥大反应的不同影响。
DOI: 10.1007/s00441-009-0807-9
发表时间: 2009
期刊: Cell and tissue research
影响因子: 3.6
作者: [Menashi,EmmanuelB, Loftus,JosephC]
通讯作者: Loftus,JosephC
Role of a Novel TROY-EGFR Complex in Gliobastoma Invasion and Resistance
  • 批准号:
    9015789
  • 项目类别:
  • 资助金额:
    $38.5万
  • 财政年份:
    2015
  • 负责人:
    JOSEPH C LOFTUS
  • 依托单位:
HTS for Identification of Novel Inhibitors of Pyk2 Activity
  • 批准号:
    9245558
  • 项目类别:
  • 资助金额:
    $40.63万
  • 财政年份:
    2015
  • 负责人:
    JOSEPH C LOFTUS
  • 依托单位:
Histone Modification and GBM Therapy
  • 批准号:
    8729254
  • 项目类别:
  • 资助金额:
    $13.38万
  • 财政年份:
    2014
  • 负责人:
    JOSEPH C LOFTUS
  • 依托单位:
FAK and Pky2 in Determination of Glioblastoma Phenotype
  • 批准号:
    7414009
  • 项目类别:
  • 资助金额:
    $26.45万
  • 财政年份:
    2005
  • 负责人:
    JOSEPH C LOFTUS
  • 依托单位:
海外基金